UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016333
Receipt number R000018952
Scientific Title Effect of branched chain amino acid with muscle strength exercise on patients with hip osteoarthritis: Confirmatory study
Date of disclosure of the study information 2015/01/25
Last modified on 2020/07/13 09:08:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of branched chain amino acid with muscle strength exercise on patients with hip osteoarthritis: Confirmatory study

Acronym

Effect of branched chain amino acid with muscle strength exercise on patients with hip osteoarthritis

Scientific Title

Effect of branched chain amino acid with muscle strength exercise on patients with hip osteoarthritis: Confirmatory study

Scientific Title:Acronym

Effect of branched chain amino acid with muscle strength exercise on patients with hip osteoarthritis

Region

Japan


Condition

Condition

Hip osteoarthritis

Classification by specialty

Orthopedics Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Using randomized control trial, This study examined the efficacy of muscle strength exercise combined with branched chain amino acid supplementation to physical function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Hip abductor strength

Key secondary outcomes

Physical activity
(Frenchay activities index)
Grip strength
10-m timed gait test
JHEQ mental status score


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Branched amino acid supplement
6g/ 1 month

Interventions/Control_2

starch 1.2g/ 1 month

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1) Patients scheduled for mini incision total hip arthroplasty.
2) Patients with no deglutition disorder.
3) Patients with osteoarthritis
4) Patients with bilateral osteoarthritis who were operated contralateral side THA

Key exclusion criteria

1) Persons with past surgical history
2) Persons with renal disorder who need to dietary restriction
3) Persons with progressive disorder of the nervous system and muscle
4) Patients scheduled for conventional total hip arthroplasty.
5) Patients scheduled for arthroplasy with osteotomy
6) Patients scheduled for arthroplasy with hip adductor muscle dehiscence
7) Patients with dementia
8) Patients with the depression or schizophrenic disorder
9) Patients with cerebro-vascular disease
10) Patients with untreated cardio
-vascular disorder
11) Patients with pregnant

Target sample size

56


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Ikeda

Organization

Tokyo Medical and Dental University Graduate school

Division name

Department of Rehabilitation Medicine

Zip code

113-8510

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan

TEL

+81-03-5803-5648

Email

tikeda-tmd@umin.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Ikeda

Organization

Tokyo Medical and Dental University Graduate school

Division name

Department of Rehabilitation Medicine

Zip code

113-8510

Address

1-5-45, Yushima, Bunkyo-ku, 113-8510 Tokyo, Japan

TEL

+81-03-5803-5648

Homepage URL


Email

tikeda-tmd@umin.ac.jp


Sponsor or person

Institute

Shonan Kamakura Joint Reconstruction Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

none

Name of secondary funder(s)

none


IRB Contact (For public release)

Organization

Tokushukai Group Ethical Committee

Address

1-8-7,Koji-machi,Chiyoda-ku,Tokyo 102-0083,Japan

Tel

+81-03-3263-4801

Email

hisamatsu@mirai-iryo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

湘南鎌倉人工関節センター(神奈川)
Shonan Kamakura Joint Reconstruction Center (Kanagawa, Japan)


Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 25 Day


Related information

URL releasing protocol

none

Publication of results

Published


Result

URL related to results and publications

https://doi.org/10.1142/S1013702518500038

Number of participants that the trial has enrolled

43

Results

There was a marginally significant difference in the main effect between the groups in 10-m timed gait time. The improvement rate in hip abductor muscle strength of the contralateral side was significantly greater in the BCAA group.

Results date posted

2020 Year 07 Month 13 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2018 Year 02 Month 01 Day

Baseline Characteristics

The eligible patients were 55 women with secondary
hip OA scheduled for primary unilateral total
hip arthroplasty (THA) with a delay of 1.5
months.

Participant flow

A one-month period of supplementation
was combined with exercise.

Adverse events

none

Outcome measures

Demographic data were collected from clinicalrecords and included age, body mass index (BMI),intervention
and prescribed analgesic medicine. Evaluations were conducted in the pre-intervention period and the post-intervention period.
Investigators assessed muscle strength and the 10-m timed gait test before and after the intervention. The Frenchay Activities Index (FAI) and the Japanese Orthopedic Association Hip-Disease Evaluation Questionnaire (JHEQ) were evaluated before the intervention. The compliance rate with home exercise was measured after the intervention.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 01 Month 11 Day

Date of IRB

2015 Year 01 Month 21 Day

Anticipated trial start date

2015 Year 01 Month 27 Day

Last follow-up date

2015 Year 09 Month 15 Day

Date of closure to data entry

2015 Year 09 Month 15 Day

Date trial data considered complete

2015 Year 09 Month 15 Day

Date analysis concluded

2015 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 01 Month 25 Day

Last modified on

2020 Year 07 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018952


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name